Family Medicine, Sports Medicine · Sugar Land, TX
NPI
1225267412
Since 2009
Specialty
Family Medicine, Sports Medicine
Code 207QS0010X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1039 Imperial Blvd Ste 303
Sugar Land, TX, 77498
Phone (713) 587-6764
Groups this clinician bills Medicare through
Medicare paid, 2024
$254K
14,111 services
Medicare patients, 2024
202
Average age 77
Drug cost, 2024
$219K
828 prescriptions
Company payments, 2025
$188
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashish K Vala was code J7322 (hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg), 8,208 times for 79 patients. In total Ashish K Vala billed 14,111 services in 57 codes, and Medicare paid $254K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-06.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 8,208 | 79 | $13.40 | $110K |
| J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 864 | 16 | $13.80 | $12K |
| 20611 Joint Injection | Office | 686 | 127 | $69.31 | $48K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 568 | 72 | $0.75 | $428 |
| 99214 Office E&M - Established | Office | 441 | 160 | $83.24 | $37K |
| J7324 Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 165 | 30 | $96.23 | $16K |
| 73564 X-ray - Lower Extremity | Office | 146 | 88 | $32.06 | $4,680 |
| 99213 Office E&M - Established | Office | 112 | 61 | $58.03 | $6,499 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 62 | 13 | $0.54 | $33.17 |
| 73030 X-ray - Upper Extremity | Office | 45 | 31 | $23.83 | $1,073 |
| 99203 Office E&M - New | Office | 40 | 40 | $69.72 | $2,789 |
| 73502 X-ray - Lower Extremity | Office | 22 | 17 | $32.52 | $716 |
| 72100 X-ray - Spine and Pelvis | Office | 18 | 18 | $25.15 | $453 |
| 72148 MRI/MRA - Spine | Office | 17 | 17 | $139.08 | $2,364 |
| 73130 X-ray - Upper Extremity | Office | 16 | 11 | $25.37 | $406 |
By year: 2022 $307K for 12,508 services; 2023 $247K for 12,408 services; 2024 $254K for 14,111 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashish K Vala prescribed most often to Medicare patients was Prednisone, with 210 prescriptions and refills. In total Ashish K Vala wrote 828 Medicare prescriptions that cost $219K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 210 | 210 | 162 | $456 |
| Diclofenac Sodium Generic | 148 | 150 | 105 | $22K |
| Diclofenac Potassium Generic | 85 | 93 | 51 | $125K |
| Gabapentin Generic | 71 | 79 | 31 | $1,039 |
| Lidocaine Generic | 68 | 68 | 55 | $1,722 |
| Naproxen Generic | 50 | 50 | 30 | $722 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 37 | 37 | 33 | $748 |
| Tramadol Hcl Generic | 21 | 21 | Under 11 | $127 |
| Meloxicam Generic | 13 | 13 | Under 11 | $94.46 |
| Relafen Ds Nabumetone | 13 | 13 | Under 11 | $39K |
| Nabumetone Generic | 12 | 12 | 12 | $296 |
Brand drugs: 19 claims; generic drugs: 809 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashish K Vala $188 ($188 in general payments such as food, travel and fees) from 4 companies. The largest payer was Fidia Pharma USA Inc. with $57.1.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.